Clearmind Medicine, Inc. (CMND)
1.14
+0.06
(+5.56%)
USD |
NASDAQ |
Mar 06, 16:00
1.17
+0.03
(+2.63%)
After-Hours: 20:00
Clearmind Medicine EPS Diluted (Quarterly) : -4.762 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tilray Brands, Inc. | -0.4072 |
| Psyence Biomedical Ltd. | 0.00 |
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.6878M |
| Total Expenses (Quarterly) | 0.6878M |
| Enterprise Value | -1.760M |
| Earnings Yield | -2.13K% |
| Normalized Earnings Yield | -2728.82 |